Preoperative thrombocytopenia and outcomes of hepatectomy for hepatocellular carcinoma

Journal of Surgical Research

Volumn 201, Issue 2, 2016, Pages 498-505

  Venkat, Raghunandan ^a   Hannallah, Jack R ^a   Krouse, Robert S ^a,b   Maegawa, Felipe B ^a,b  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b SOUTHERN ARIZONA VA HEALTH CARE SYSTEM   (United States)

Author keywords

Clinical outcomes; Hepatectomy; Hepatocellular carcinoma; NSQIP; Portal hypertension; Thrombocytopenia

Indexed keywords

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; BLOOD TRANSFUSION; CANCER SURGERY; CARDIOPULMONARY COMPLICATION; FEMALE; HUMAN; INTUBATION; KIDNEY FAILURE; LIVER CELL CARCINOMA; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; PNEUMONIA; PORTAL HYPERTENSION; POSTOPERATIVE COMPLICATION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; REPEAT PROCEDURE; SEPTIC SHOCK; SURGICAL MORTALITY; THROMBOCYTE COUNT; THROMBOCYTOPENIA; TREATMENT OUTCOME; VERY ELDERLY; CARCINOMA, HEPATOCELLULAR; COMPLICATION; EPIDEMIOLOGY; LIVER NEOPLASMS; MIDDLE AGED; MORTALITY; RETROSPECTIVE STUDY; UNITED STATES;

AGED; AGED, 80 AND OVER; CARCINOMA, HEPATOCELLULAR; FEMALE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PREOPERATIVE PERIOD; RETROSPECTIVE STUDIES; THROMBOCYTOPENIA; UNITED STATES;

EID: 84982902963     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2015.08.038     Document Type: Article

References (45)

1. [1] El-Serag, H.B., Davila, J.A., Petersen, N.J., McGlynn, K.A., The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann Intern Med, 139, 2003, 817.
2. [2] Thompson Coon, J., Rogers, G., Hewson, P., et al. Surveillance of cirrhosis for hepatocellular carcinoma: systematic review and economic analysis. Health Technol Assess, 11, 2007, 1.
3. [3] Nordenstedt, H., White, D.L., El-Serag, H.B., The changing pattern of epidemiology in hepatocellular carcinoma. Dig Liver Dis, 42(Suppl 3), 2010, S206.
4. [4] American Cancer Society. Cancer facts and figures 2014. 2014, American Cancer Society, Atlanta, GA.
5. [5] Llovet, J.M., Di Bisceglie, A.M., Bruix, J., et al. Design and endpoints of clinical trials in hepatocellular carcinoma. J Natl Cancer Inst, 100, 2008, 698.
6. [6] Forner, A., Reig, M.E., de Lope, C.R., Bruix, J., Current strategy for staging and treatment: the BCLC update and future prospects. Semin Liver Dis, 30, 2010, 61.
7. [7] Llovet, J.M., Bruix, J., Gores, G.J., Surgical resection versus transplantation for early hepatocellular carcinoma: clues for the best strategy. Hepatology, 31, 2000, 1019.
8. [8] Farinati, F., Giacomin, A., Vanin, V., et al. Liver transplantation for hepatocellular carcinoma in clinical practice: the lesson from a 20-year multicentre experience in Italy. Eur J Gastroenterol Hepatol, 24, 2012, 195.
9. [9] Fu, C., Liu, N., Deng, Q., Li, X., Ma, K., Bie, P., Radiofrequency ablation vs. surgical resection on the treatment of patients with small hepatocellular carcinoma: a system review and meta-analysis of five randomized controlled trials. Hepato-gastroenterology, 61, 2014, 1722.
10. [10] Jarnagin, W.R., Gonen, M., Fong, Y., et al. Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade. Ann Surg, 236, 2002, 397 discussion 406–407.
11. [11] Poon, R.T., Fan, S.T., Lo, C.M., et al. Improving perioperative outcome expands the role of hepatectomy in management of benign and malignant hepatobiliary diseases: analysis of 1222 consecutive patients from a prospective database. Ann Surg, 240, 2004, 698 discussion 708–710.
12. [12] Schiffman, S.C., Woodall, C.E., Kooby, D.A., et al. Factors associated with recurrence and survival following hepatectomy for large hepatocellular carcinoma: a multicenter analysis. J Surg Oncol, 101, 2010, 105.
13. [13] Lim, K.C., Wang, V.W., Siddiqui, F.J., et al. Cost-effectiveness analysis of liver resection versus transplantation for early hepatocellular carcinoma within the Milan criteria. Hepatology, 61, 2015, 227.
14. [14] Pugh, R.N., Murray-Lyon, I.M., Dawson, J.L., Pietroni, M.C., Williams, R., Transection of the oesophagus for bleeding oesophageal varices. The Br J Surg, 60, 1973, 646.
15. [15] Lau, H., Man, K., Fan, S.T., Yu, W.C., Lo, C.M., Wong, J., Evaluation of preoperative hepatic function in patients with hepatocellular carcinoma undergoing hepatectomy. The Br J Surg, 84, 1997, 1255.
16. [16] Cucchetti, A., Ercolani, G., Vivarelli, M., et al. Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis. Liver Transpl, 12, 2006, 966.
17. [17] Teh, S.H., Sheppard, B.C., Schwartz, J., Orloff, S.L., Model for end-stage liver disease score fails to predict perioperative outcome after hepatic resection for hepatocellular carcinoma in patients without cirrhosis. Am J Surg, 195, 2008, 697.
18. [18] Delis, S.G., Bakoyiannis, A., Biliatis, I., Athanassiou, K., Tassopoulos, N., Dervenis, C., Model for end-stage liver disease (MELD) score, as a prognostic factor for post-operative morbidity and mortality in cirrhotic patients, undergoing hepatectomy for hepatocellular carcinoma. HPB, 11, 2009, 351.
19. [19] Hsu, K.Y., Chau, G.Y., Lui, W.Y., Tsay, S.H., King, K.L., Wu, C.W., Predicting morbidity and mortality after hepatic resection in patients with hepatocellular carcinoma: the role of model for end-stage liver disease score. World J Surg, 33, 2009, 2412.
20. [20] Lam, C.M., Fan, S.T., Lo, C.M., Wong, J., Major hepatectomy for hepatocellular carcinoma in patients with an unsatisfactory indocyanine green clearance test. The Br J Surg, 86, 1999, 1012.
21. [21] Bruix, J., Castells, A., Bosch, J., et al. Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. Gastroenterology, 111, 1996, 1018.
22. [22] Bruix, J., Sherman, M., Llovet, J.M., et al. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol, 35, 2001, 421.
23. [23] Bruix, J., Sherman, M., Practice guidelines committee AAftSoLD. Management of hepatocellular carcinoma. Hepatology, 42, 2005, 1208.
24. [24] Khuri, S.F., Daley, J., Henderson, W., et al. The Department of Veterans Affairs' NSQIP: the first national, validated, outcome-based, risk-adjusted, and peer-controlled program for the measurement and enhancement of the quality of surgical care. National VA Surgical Quality Improvement Program. Ann Surg, 228, 1998, 491.
25. [25] Khuri, S.F., Henderson, W.G., Daley, J., et al. Successful implementation of the department of Veterans Affairs' national surgical quality improvement program in the private sector: the patient safety in surgery study. Ann Surg, 248, 2008, 329.
26. [26] Al-Refaie, W.B., Parsons, H.M., Henderson, W.G., et al. Major cancer surgery in the elderly: results from the American College of Surgeons National Surgical Quality Improvement Program. Ann Surg, 251, 2010, 311.
27. [27] Merkow, R.P., Bilimoria, K.Y., McCarter, M.D., Bentrem, D.J., Effect of body mass index on short-term outcomes after colectomy for cancer. J Am Coll Surg, 208, 2009, 53.
28. [28] Malinchoc, M., Kamath, P.S., Gordon, F.D., Peine, C.J., Rank, J., ter Borg, P.C., A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts. Hepatology, 31, 2000, 864.
29. [29] Venkat, R., Valdivia, P.L., Guerrero, M.A., Resident participation and postoperative outcomes in adrenal surgery. The J Surg Res, 190, 2014, 559.
30. [30] Ingraham, A.M., Cohen, M.E., Bilimoria, K.Y., Pritts, T.A., Ko, C.Y., Esposito, T.J., Comparison of outcomes after laparoscopic versus open appendectomy for acute appendicitis at 222 ACS NSQIP hospitals. Surgery, 148, 2010, 625 discussion 635–637.
31. [31] Cohen, M.E., Bilimoria, K.Y., Ko, C.Y., Richards, K., Hall, B.L., Variability in length of stay after colorectal surgery: assessment of 182 hospitals in the national surgical quality improvement program. Ann Surg, 250, 2009, 901.
32. [32] Rubin, D.B., Schenker, N., Multiple imputation in health-care databases: an overview and some applications. Stat Med, 10, 1991, 585.
33. [33] Grazi, G.L., Ercolani, G., Pierangeli, F., et al. Improved results of liver resection for hepatocellular carcinoma on cirrhosis give the procedure added value. Ann Surg, 234, 2001, 71.
34. [34] Tang, Y.H., Zhu, W.J., Wen, T.F., Influence of clinically significant portal hypertension on hepatectomy for hepatocellular carcinoma: a meta-analysis. Asian Pac J Cancer Prev, 15, 2014, 1649.
35. [35] Choi, S.B., Kim, H.J., Song, T.J., Ahn, H.S., Choi, S.Y., Influence of clinically significant portal hypertension on surgical outcomes and survival following hepatectomy for hepatocellular carcinoma: a systematic review and meta-analysis. J hepato-biliary-pancreatic Sci, 21, 2014, 639.
36. [36] Hernandez-Gea, V., Turon, F., Berzigotti, A., Villanueva, A., Management of small hepatocellular carcinoma in cirrhosis: focus on portal hypertension. World J Gastroenterol, 19, 2013, 1193.
37. [37] Llovet, J.M., Bru, C., Bruix, J., Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis, 19, 1999, 329.
38. [38] Sugimachi, K., Ikeda, Y., Tomikawa, M., et al. Appraisal of hepatic resection in the treatment of hepatocellular carcinoma with severe thrombocytopenia. World J Surg, 32, 2008, 1077.
39. [39] Cucchetti, A., Ercolani, G., Vivarelli, M., et al. Is portal hypertension a contraindication to hepatic resection?. Ann Surg, 250, 2009, 922.
40. [40] Maithel, S.K., Kneuertz, P.J., Kooby, D.A., et al. Importance of low preoperative platelet count in selecting patients for resection of hepatocellular carcinoma: a multi-institutional analysis. J Am Coll Surg, 212, 2011, 638 discussion 648–650.
41. [41] Boleslawski, E., Petrovai, G., Truant, S., et al. Hepatic venous pressure gradient in the assessment of portal hypertension before liver resection in patients with cirrhosis. The Br J Surg, 99, 2012, 855.
42. [42] Giannini, E.G., Savarino, V., Farinati, F., Influence of clinically significant portal hypertension on survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients. Liver Int, 33, 2013, 1594.
43. [43] Alkozai, E.M., Nijsten, M.W., de Jong, K.P., et al. Immediate postoperative low platelet count is associated with delayed liver function recovery after partial liver resection. Ann Surg, 251, 2010, 300.
44. [44] Murata, S., Ohkohchi, N., Matsuo, R., Ikeda, O., Myronovych, A., Hoshi, R., Platelets promote liver regeneration in early period after hepatectomy in mice. World J Surg, 31, 2007, 808.
45. [45] Starlinger, P., Assinger, A., Haegele, S., et al. Evidence for serotonin as a relevant inducer of liver regeneration after liver resection in humans. Hepatology, 60, 2014, 257.